As the first quarter wraps up in the cannabis market, it’s important for investors to look beyond daily and weekly returns to see how cannabis stocks have performed so far in a year.

While stock performance doesn’t entirely determine what type of announcements a company may have had, it does indicate confidence from the public markets. The companies in this list have seen satisfying returns this year thanks to intriguing critical announcements and compelling ratings from experts in the market.


Despite seeing losses all over the industry, some companies have been been able to pull through success in the midst of a wide ranging market correction for cannabis stocks.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

With that in mind, the Investing News Network (INN) brings investors a closer look at some of the top gaining cannabis stocks so far in 2018. Read below to find a list per each Canadian exchange and a runner up list of cannabis stocks.

The data used to rank these stocks was collected through a combination of Google Finance and Yahoo Finance. All year-to-date figures are accurate as of Monday (April 16).

Canadian Securities Exchange

Choom Holdings (CSE:CHOO)

Year-to-date percentage increase: 55.93 percent; market cap: $63.72 million; stock price C$0.92

Choom launched on the CSE last year and since then the company has worked to put its name on the minds of investors as a brands-focused enterprise. Choom appeals to cannabis consumers as a lifestyle decision.

This quarter, Choom has been making moves to warrant the increase in its value. From recent acquisitions of late stage ACMPR applicants in Canada, to partnerships with well established entities and the potential for the creation of Choom branded retail cannabis stores where it may be legal to do so.

iAnthus Holdings (CSE:IAN)

Year-to-date percentage increase: 45.55 percent; market cap: $175.61 million; stock price C$4.20

iAnthus is a US-focused operator of cannabis businesses. The company raises money in Canada through the CSE and allows investors exposure to a booming American market in the states marijuana is legal.

During the last quarter the company was added into the CSE 25 Index, a sign of its growth among the competitive exchange. The company currently holds assets and operations in Massachusetts, Florida, Colorado, Vermont and New Mexico with the potential to add New York into this list.

TSX Venture Exchange

Newstrike Resources (TSXV:HIP)

Year-to-date percentage increase:  65.62 percent; market cap: $487.21M; stock price C$1.06

Newstrike was left behind one of the biggest deal reversals in the cannabis industry. However, the company was able to raise capital quickly after the fallout of its failed partnership with CanniMed Therapeutics (TSX:CMED).

Jay Wilgar CEO of Newstrike told INN he expects the focus on branding for Newstrike to pay off once the recreational market in Canada opens later this year.

The company’s brand, Up Cannabis, announced last quarter its facility in the Niagara region had received its official license for the production of cannabis. The company expects to get its first harvest in the third quarter of 2018.

National Access Cannabis (TSXV:NAC)

Year-to-date percentage increase: 50.77 percent; market cap: $129.20 million; stock price C$0.99

This company has established successful partnerships with a variety of cannabis players in the public and private space. During this quarter NAC obtained a critical retail license in the province of Manitoba, meaning the company will be allowed to create retail cannabis stores to sell its products.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

One of its partnerships is with CannaRoyalty (CSE:CRZ) a US-focused cannabis operator. However the most recent announcement from the companies hints at the potential for CannaRoyalty to bring its line of branded products to the Canadian market with help from NAC.

Toronto Stock Exchange

MedReleaf (TSX:LEAF)

Year-to-date percentage increase: 43.77 percent; market cap: $1.93 B; stock price C$19.98

In the first quarter MedReleaf placed down its bets for the recreational market by launching two new brands, San Rafael ‘71 and AltaVie, meant to appeal adult-use consumers of cannabis. Neil Closner, CEO of MedReleaf, told INN the largest market available for his company is the international medical cannabis one.

As part of the company’s most recent quarterly update Closner said the company holds a “strong balance sheet” thanks to a C$192.5 million worth of equity capital raised since December.

The company managed to obtain one of the coveted supply agreements with the province of Quebec for retail cannabis products. MedReleaf will be allowed to to supply 8,000 kilograms per year for a three-year deal with the province.

Canopy Growth (TSX:WEED)

Year-to-date: -4.54 percent; market cap: 6.02 B; stock price C$31.07

Despite seeing a loss on their per share value, Canopy remains the biggest cannabis company in the public market, and from all the TSX stocks, WEED was the one with the lowest decrease so far in 2018.

The industry has seen catalyst announcements strong enough to boost massive stocks such as Canopy, but experts agree until the Canadian market is fully operational with recreational sales, it will be difficult to fully evaluate the value of these cannabis giants.

During the quarter Canopy announced it had received a cultivation license for 400,00 square feet worth of growing space in B.C. operated by the local Tweed division. The company also continued its partnerships across the cannabis space thanks to a new deal with Sunniva (CSE:SNN) for two years that will bring 90,000 extra kilograms of dried cannabis to Canopy.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Trading resumes in:

Company: 4Front Ventures Corp.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Tactile Systems Technology (NASDAQ:TCMD)
Class Period:
May 7, 2018 – June 8, 2020
Deadline: November 30, 2020
For more info: www.bgandg.com/tcmd

Keep reading... Show less

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less